ViewRay, which markets the only MRI radiation therapy system that images and treats patients simultaneously, announced terms for its IPO on Friday. The Oakwood Village, OH-based company plans to raise $52 million by offering 4 million shares at a price range of $12 to $14. At the midpoint of the proposed range, ViewRay would command a fully diluted market value of $204 million.
ViewRay, which was founded in 2004 and booked $6 million in sales for the 12 months ended December 31, 2014, plans to list on the NASDAQ under the symbol VRAY. Cowen & Company and Stifel are the joint bookrunners on the deal. It is expected to price during the week of March 23, 2015.
